50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
GAMMAGARD
AEO Score: 6/10
Monitoring for AI engine activity
In the Engagemii AEO index
#22,522 of 452,649 in Healthcare for AI visibility
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. GAMMAGARD just got measured.
6/10 means GAMMAGARD is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.
About GAMMAGARD
GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% for multifocal motor neuropathy (MMN). See Information for Patients, including WARNING about blood clots, decreased kidney function, and kidney failure.
Key Topics
Details
Industry: Healthcare
morethanmuscleweakness.comAI Visibility Breakdown
5
Structured Data
9
Content Structure
7
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
3
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for GAMMAGARD.
Source & Attribution
Scored by Engagemii on July 11, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/morethanmuscleweakness
Cite this score: Engagemii (2026). "AEO Score for GAMMAGARD." Retrieved from https://engagemii.com/aeo/brands/morethanmuscleweakness
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform